{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:38:56Z","timestamp":1773693536660,"version":"3.50.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Urinary liver-type fatty acid-binding protein (L-FABP) has been known as a potential biomarker for acute kidney injury. It has also been suggested to have an effective predictive value for cardiovascular mortality in patients with diabetes or critically ill condition. Therefore, this study aimed to examine the ability of urinary L-FABP in predicting mid-term cardiovascular morbidity and mortality in patients with hypertension.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Urinary L-FABP levels in stable outpatients without diabetes who were treated with antihypertensive drugs were measured, and a 5-year follow-up was planned. The primary end-point was a combination of acute heart failure requiring hospitalization, myocardial infarction, stroke, and cardiovascular death. The secondary end-point was kidney disease progression defined as a relative decline in the estimated glomerular filtration rate of \u226530% from the baseline.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 197 patients were recruited. Primary and secondary end-points occurred in 24 (12.2%) and 42 (21.3%) patients, respectively, during a median follow-up of 5.7 years. Patients with urinary L-FABP levels higher than the upper limit (8.4 \u00b5g\/g creatinine) were more likely to reach the primary (30.43% vs. 9.77%; P = 0.003) and secondary end-points (56.52% vs. 16.67%; P &amp;lt; 0.001) than those with urinary L-FABP levels within the normal limits. Urinary L-FABP level was independently associated with both primary (hazard ratio (HR) 1.21; P = 0.03) and secondary end-points (HR 1.19; P = 0.02).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study demonstrated that increased urinary L-FABP levels may predict adverse cardiovascular events and renal dysfunction progression even among stable nondiabetic patients with hypertension.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpaa035","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T12:19:53Z","timestamp":1583237993000},"page":"604-609","source":"Crossref","is-referenced-by-count":7,"title":["Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Major Adverse Cardiovascular Events in Patients With Hypertension"],"prefix":"10.1093","volume":"33","author":[{"given":"Yousaku","family":"Okubo","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences , Hiroshima, Japan"},{"name":"Department of Cardiovascular Medicine, Shimokamagari Public Hospital , Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences , Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehito","family":"Tokuyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences , Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Hironobe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences , Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences , Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ikeuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences , Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences , Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuki","family":"Kihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences , Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"2022100317082588900_CIT0001","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1523-1755.2005.00397.x","article-title":"Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study","volume":"68","author":"Ninomiya","year":"2005","journal-title":"Kidney Int"},{"key":"2022100317082588900_CIT0002","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2215\/CJN.07800811","article-title":"Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR","volume":"7","author":"Rahman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022100317082588900_CIT0003","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIRCULATIONAHA.108.792903","article-title":"Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study","volume":"118","author":"Ninomiya","year":"2008","journal-title":"Circulation"},{"key":"2022100317082588900_CIT0004","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.105.538132","article-title":"Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study","volume":"112","author":"Arnl\u00f6v","year":"2005","journal-title":"Circulation"},{"key":"2022100317082588900_CIT0005","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2012.16817","article-title":"Age and association of kidney measures with mortality and end-stage renal disease","volume":"308","author":"Hallan","year":"2012","journal-title":"JAMA"},{"key":"2022100317082588900_CIT0006","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(12)61272-0","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis","volume":"380","author":"Mahmoodi","year":"2012","journal-title":"Lancet"},{"key":"2022100317082588900_CIT0007","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"key":"2022100317082588900_CIT0008","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1001\/archinte.164.22.2459","article-title":"Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial","volume":"164","author":"de Leeuw","year":"2004","journal-title":"Arch Intern Med"},{"key":"2022100317082588900_CIT0009","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygeno.2008.08.003","article-title":"A novel fatty acid-binding protein (FABP) gene resulting from tandem gene duplication in mammals: transcription in rat retina and testis","volume":"92","author":"Liu","year":"2008","journal-title":"Genomics"},{"key":"2022100317082588900_CIT0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.nutr.27.061406.093710","article-title":"The emerging functions and mechanisms of mammalian fatty acid-binding proteins","volume":"28","author":"Storch","year":"2008","journal-title":"Annu Rev Nutr"},{"key":"2022100317082588900_CIT0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2006.05.038","article-title":"Urinary fatty acid binding protein in renal disease","volume":"374","author":"Kamijo-Ikemori","year":"2006","journal-title":"Clin Chim Acta"},{"key":"2022100317082588900_CIT0012","doi-asserted-by":"crossref","first-page":"F669","DOI":"10.1152\/ajprenal.90513.2008","article-title":"Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury","volume":"296","author":"Noiri","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022100317082588900_CIT0013","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/ki.2010.5","article-title":"Urinary liver fatty acid-binding protein: another novel biomarker of acute kidney injury","volume":"77","author":"McMahon","year":"2010","journal-title":"Kidney Int"},{"key":"2022100317082588900_CIT0014","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cca.2013.05.020","article-title":"Urinary liver type fatty acid binding protein in diabetic nephropathy","volume":"424","author":"Kamijo-Ikemori","year":"2013","journal-title":"Clin Chim Acta"},{"key":"2022100317082588900_CIT0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.athoracsur.2011.10.048","article-title":"Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery","volume":"93","author":"Katagiri","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2022100317082588900_CIT0016","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2215\/CJN.10971012","article-title":"Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery","volume":"8","author":"Parikh","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022100317082588900_CIT0017","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1097\/CCM.0b013e3181eedac0","article-title":"Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury","volume":"38","author":"Doi","year":"2010","journal-title":"Crit Care Med"},{"key":"2022100317082588900_CIT0018","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.ajkd.2012.10.016","article-title":"Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis","volume":"61","author":"Susantitaphong","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2022100317082588900_CIT0019","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00380-014-0538-z","article-title":"Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography","volume":"30","author":"Torregrosa","year":"2015","journal-title":"Heart Vessels"},{"key":"2022100317082588900_CIT0020","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s00125-017-4328-x","article-title":"Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes","volume":"60","author":"Panduru","year":"2017","journal-title":"Diabetologia"},{"key":"2022100317082588900_CIT0021","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10157-015-1144-9","article-title":"Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD","volume":"20","author":"Matsui","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"2022100317082588900_CIT0022","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.kint.2016.08.003","article-title":"Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate","volume":"90","author":"Matsushita","year":"2016","journal-title":"Kidney Int"},{"key":"2022100317082588900_CIT0023","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.ajkd.2014.08.018","article-title":"GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials","volume":"64","author":"Lambers Heerspink","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2022100317082588900_CIT0024","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"key":"2022100317082588900_CIT0025","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/j.ajkd.2014.08.017","article-title":"GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials","volume":"64","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2022100317082588900_CIT0026","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1053\/j.ajkd.2014.08.019","article-title":"Utility and validity of estimated GFR based surrogate time-to-event end points in CKD: a simulation study","volume":"64","author":"Greene","year":"2014","journal-title":"Am J Kidney Dis."},{"key":"2022100317082588900_CIT0027","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"2022100317082588900_CIT0028","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.ki.5000284","article-title":"The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population","volume":"69","author":"Irie","year":"2006","journal-title":"Kidney Int"},{"key":"2022100317082588900_CIT0029","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1161\/STROKEAHA.109.550707","article-title":"Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study","volume":"40","author":"Kokubo","year":"2009","journal-title":"Stroke"},{"key":"2022100317082588900_CIT0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00004872-200304000-00013","article-title":"Blood pressure and cardiovascular disease in the Asia Pacific region","volume":"21","author":"Lawes","year":"2003","journal-title":"J Hypertens"},{"key":"2022100317082588900_CIT0031","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","article-title":"2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC Task Force for the management of arterial hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"key":"2022100317082588900_CIT0032","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/hr.2008.27","article-title":"Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk","volume":"32","author":"Ito","year":"2009","journal-title":"Hypertens Res"},{"key":"2022100317082588900_CIT0033","first-page":"2073","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume-title":"Lancet","author":"Matsushita","year":"2010"},{"key":"2022100317082588900_CIT0034","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2010.124","article-title":"The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease","volume":"6","author":"Mimura","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"2022100317082588900_CIT0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1681\/ASN.2005070757","article-title":"Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure","volume":"17","author":"Nangaku","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2022100317082588900_CIT0036","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/eurheartj\/ehr190","article-title":"Clinical outcome of renal tubular damage in chronic heart failure","volume":"32","author":"Damman","year":"2011","journal-title":"Eur Heart J"},{"key":"2022100317082588900_CIT0037","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1046\/j.1523-1755.1999.00721.x","article-title":"The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?","volume":"56","author":"Gilbert","year":"1999","journal-title":"Kidney Int"},{"key":"2022100317082588900_CIT0038","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2337\/dc12-1298","article-title":"Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy","volume":"36","author":"Araki","year":"2013","journal-title":"Diabetes Care"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpaa035\/32961784\/hpaa035.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/33\/7\/604\/46333593\/ajh_33_7_604.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/33\/7\/604\/46333593\/ajh_33_7_604.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T17:13:23Z","timestamp":1664817203000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/33\/7\/604\/5802677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,3,10]]},"published-print":{"date-parts":[[2020,7,18]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpaa035","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,3,10]]}}}